Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Cat . Non | Espèces | Description du produit | Structure | Pureté | Caractéristique |
---|---|---|---|---|---|
PSA-M82Ea | Mouse | Biotinylated Mouse PSCA Protein, His,Avitag™, low endotoxin (MALS verified) | |||
PSA-M82E3 | Mouse | Biotinylated Mouse PSCA Protein, His,Avitag™ (MALS verified) |
|
||
PSA-H82E3 | Human | Biotinylated Human PSCA Protein, His,Avitag™ (MALS verified) |
|
||
PSA-H52H6 | Human | Human PSCA Protein, His Tag |
|
2e5 of anti-PSCA CAR-293 cells were stained with 100 μL of 3 μg/mL of Biotinylated Human PSCA, His,Avitag (Cat. No. PSA-H82E3) and negative control protein respectively, washed and then followed by PE-SA antibody and analyzed with FACS (Routinely tested).
Immobilized Human PSCA, His Tag (Cat. No. PSA-H52H6) at 1 μg/mL (100 μL/well) can bind Anti-PSCA Antibody,Human IgG1 with a linear range of 0.2-1 ng/mL (QC tested).
The purity of Biotinylated Mouse PSCA, His,Avitag (Cat. No. PSA-M82Ea) is more than 95% and the molecular weight of this protein is around 18-26 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes (City of Hope Medical Center) | Phase 1 Clinical | City Of Hope National Medical Center | Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms | Details | |
124-iodine-labeled PSCA targeting minibody (ImaginAb) | Phase 1 Clinical | University Of California At Los Angeles | Pancreatic Neoplasms; Urinary Bladder Neoplasms; Prostatic Neoplasms | Details | |
Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes (City of Hope Medical Center) | Phase 1 Clinical | City Of Hope National Medical Center | Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms | Details | |
124-iodine-labeled PSCA targeting minibody (ImaginAb) | Phase 1 Clinical | University Of California At Los Angeles | Pancreatic Neoplasms; Urinary Bladder Neoplasms; Prostatic Neoplasms | Details |
This web search service is supported by Google Inc.